Cargando...
Nafamostat mesylate attenuates the pathophysiologic sequelae of neurovascular ischemia
Nafamostat mesylate, an apparent soi-disant panacea of sorts, is widely used to anticoagulate patients undergoing hemodialysis or cardiopulmonary bypass, mitigate the inflammatory response in patients diagnosed with acute pancreatitis, and reverse the coagulopathy of patients experiencing the common...
Guardado en:
| Publicado en: | Neural Regen Res |
|---|---|
| Autores principales: | , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Wolters Kluwer - Medknow
2020
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7749469/ https://ncbi.nlm.nih.gov/pubmed/32594033 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/1673-5374.284981 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|